WO2024141787 - HYDROGEL BEAD-BASED PLATFORM FOR HIGH THROUGHPUT SCREENING OF IMMUNOMODULATORY PEPTIDES AND DESIGNER PEPTIDES FOR DENDRITIC CELLS/MACROPHAGE REPROGRAMMING

National phase entry is expected:
Publication Number WO/2024/141787
Publication Date 04.07.2024
International Application No. PCT/IB2023/000790
International Filing Date 27.12.2023
Title **
[English] HYDROGEL BEAD-BASED PLATFORM FOR HIGH THROUGHPUT SCREENING OF IMMUNOMODULATORY PEPTIDES AND DESIGNER PEPTIDES FOR DENDRITIC CELLS/MACROPHAGE REPROGRAMMING
[French] PLATEFORME À BASE DE BILLES D'HYDROGEL AUX FINS DU CRIBLAGE À HAUT DÉBIT DE PEPTIDES IMMUNOMODULATEURS ET DE PEPTIDES DE CONCEPTION POUR LA REPROGRAMMATION DE CELLULES DENDRITIQUES/MACROPHAGES
Applicants **
THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors
CHUNG, Jin Teng
LAU, Chi Ming, Laurence
CHAU, Ying
Priority Data
63/477,558   28.12.2022   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2009
EPO Filing, Examination, Granting12696
Japan Filing, Examination, Granting2147
South Korea Filing, Examination, Granting2042
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 23,634

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] Provided is a novel bead-based platform that can be used to screen various immune active peptides and designer peptide candidates and combinations for their immunogenic or tolerogenic potential. More specifically, the platform uses peptides that are specified by parameters to increase their efficiency on immune cell differentiation.[French] La présente invention concerne une nouvelle plateforme à base de billes qui peut être utilisée pour cribler divers peptides actifs immunitaires et peptides candidats de conception et des combinaisons pour leur potentiel immunogène ou tolérogène. Plus précisément, la présente invention utilise des peptides qui sont spécifiés par des paramètres pour augmenter leur efficacité en ce qui concerne la différenciation cellulaire immunitaire.

Rejoining the server...